Susquehanna International Group, LLP Verona Pharma PLC Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Verona Pharma PLC stock. As of the latest transaction made, Susquehanna International Group, LLP holds 968,800 shares of VRNA stock, worth $104 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
968,800
Previous 33,655
2778.62%
Holding current value
$104 Million
Previous $2.14 Million
4189.75%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VRNA
# of Institutions
321Shares Held
76.7MCall Options Held
977KPut Options Held
3.12M-
Janus Henderson Group PLC London, X06.13MShares$656 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$589 Million22.87% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$441 Million16.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million16.88% of portfolio
-
Rtw Investments, LP New York, NY3.05MShares$326 Million4.43% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...